87 related articles for article (PubMed ID: 20184237)
1. [Disappearance of paroxysmal perceptual alteration by switching to aripiprazole in a schizophrenic patient].
Kondo M; Ikejiri Y; Hanatani T; Sumi N
Seishin Shinkeigaku Zasshi; 2010; 112(1):23-30. PubMed ID: 20184237
[TBL] [Abstract][Full Text] [Related]
2. [Paroxysmal perceptual alteration in comparison with hallucination--a review of its clinical reports and discussion of its pathophysiological mechanism in the present day, when second generation antipsychotics are widely used].
Watanabe K
Seishin Shinkeigaku Zasshi; 2009; 111(2):127-36. PubMed ID: 19378769
[TBL] [Abstract][Full Text] [Related]
3. Effects of aripiprazole and haloperidol on progression to schizophrenia-like behavioural abnormalities and apoptosis in rodents.
Abekawa T; Ito K; Nakagawa S; Nakato Y; Koyama T
Schizophr Res; 2011 Jan; 125(1):77-87. PubMed ID: 20833512
[TBL] [Abstract][Full Text] [Related]
4. Aripiprazole and haloperidol: beneficial combination antipsychotic therapy for a schizophrenic patient.
Kuo J; Hwu HG
Clin Neuropharmacol; 2008; 31(3):173-5. PubMed ID: 18520984
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Paroxysmal Perceptual Alteration in Catatonic Schizophrenia by Switching to Aripiprazole from Risperidone: A Case Report.
Yamashita S; Miyaoka T; Nagahama M; Ieda M; Tsuchie K; Wake R; Horiguchi J
Clin Schizophr Relat Psychoses; 2016; 10(1):37-40. PubMed ID: 24047761
[TBL] [Abstract][Full Text] [Related]
6. Switching schizophrenia patients from typical neuroleptics to aripiprazole: effects on working memory dependent functional activation.
Schlagenhauf F; Dinges M; Beck A; Wüstenberg T; Friedel E; Dembler T; Sarkar R; Wrase J; Gallinat J; Juckel G; Heinz A
Schizophr Res; 2010 May; 118(1-3):189-200. PubMed ID: 20189356
[TBL] [Abstract][Full Text] [Related]
7. Aripiprazole in combination with other antipsychotic drugs may worsen psychosis.
Adan-Manes J; Garcia-Parajua P
J Clin Pharm Ther; 2009 Apr; 34(2):245-6. PubMed ID: 19250146
[TBL] [Abstract][Full Text] [Related]
8. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.
Lu ML; Shen WW; Chen CH
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1978-81. PubMed ID: 18848860
[TBL] [Abstract][Full Text] [Related]
9. Aripiprazole: pharmacodynamics of a dopamine partial agonist for the treatment of schizophrenia.
Gründer G; Kungel M; Ebrecht M; Göröcs T; Modell S
Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S21-5. PubMed ID: 16508892
[TBL] [Abstract][Full Text] [Related]
10. Aripiprazole.
Fleischhacker WW
Expert Opin Pharmacother; 2005 Oct; 6(12):2091-101. PubMed ID: 16197361
[TBL] [Abstract][Full Text] [Related]
11. Unique pharmacological profile of aripiprazole as the phasic component buster.
Hamamura T; Harada T
Psychopharmacology (Berl); 2007 Apr; 191(3):741-3. PubMed ID: 17205315
[TBL] [Abstract][Full Text] [Related]
12. Dopamine receptor downregulation: an alternative strategy for schizophrenia treatment.
Tsai SJ
Med Hypotheses; 2004; 63(6):1047-50. PubMed ID: 15504573
[TBL] [Abstract][Full Text] [Related]
13. Persistent hiccups associated with switching from risperidone to aripiprazole in a schizophrenic patient with cerebral palsy.
Yeh YW
Clin Neuropharmacol; 2011; 34(4):135-6. PubMed ID: 21768798
[TBL] [Abstract][Full Text] [Related]
14. [The syndromes of oculogyric crisis and paroxysmal perceptual alteration in chronic schizophrenic patients--a clinical inquiry into their pathophysiology].
Watanabe K
Seishin Shinkeigaku Zasshi; 1991; 93(3):151-89. PubMed ID: 1676849
[TBL] [Abstract][Full Text] [Related]
15. Is clozapine-aripiprazole combination a useful regime in the management of treatment-resistant schizophrenia?
Karunakaran K; Tungaraza TE; Harborne GC
J Psychopharmacol; 2007 Jun; 21(4):453-6. PubMed ID: 17050662
[TBL] [Abstract][Full Text] [Related]
16. Improvement of tardive dyskinesia and dystonia associated with aripiprazole following a switch to quetiapine: case report and review of the literature.
Ono S; Suzuki Y; Shindo M; Endo T; Fukui N; Sugai T; Someya T
J Clin Pharm Ther; 2012 Jun; 37(3):370-2. PubMed ID: 22023382
[TBL] [Abstract][Full Text] [Related]
17. Aripiprazole in treatment-refractory schizophrenia.
Hsu WY; Lee CI; Chiu NY; Kahn DA
J Psychiatr Pract; 2009 May; 15(3):221-6. PubMed ID: 19461396
[TBL] [Abstract][Full Text] [Related]
18. Favourable results in treatment-resistant schizophrenic patients under combination of aripiprazole with clozapine.
Mossaheb N; Spindelegger C; Asenbaum S; Fischer P; Barnas C
World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):502-5. PubMed ID: 20218805
[TBL] [Abstract][Full Text] [Related]
19. Aripiprazole: pharmacology, efficacy, safety and tolerability.
Kinghorn WA; McEvoy JP
Expert Rev Neurother; 2005 May; 5(3):297-307. PubMed ID: 15938662
[TBL] [Abstract][Full Text] [Related]
20. Paroxysmal Perceptual Alteration: Drug-Induced Phenomenon or Schizophrenic Psychopathology?
Praharaj SK; Kongasseri S; Acharya M
Am J Ther; 2016; 23(2):e628-30. PubMed ID: 26954463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
